Edition:
United States

Express Scripts Holding Co (ESRX.O)

ESRX.O on Nasdaq

71.75USD
20 Jan 2017
Change (% chg)

$-0.70 (-0.97%)
Prev Close
$72.45
Open
$72.55
Day's High
$72.92
Day's Low
$71.63
Volume
4,642,215
Avg. Vol
3,938,970
52-wk High
$80.02
52-wk Low
$64.46

Select another date:

Mon, Jan 9 2017

Whistleblower case against Express Scripts dismissed

A federal judge in Delaware has dismissed a whistleblower lawsuit accusing pharmacy benefit manager Medco Health Solutions Inc, now part of Express Scripts Holding Co, of taking kickbacks from AstraZeneca PLC to promote its drugs, finding the case was barred by earlier, similar lawsuits.

Express Scripts sees no let-up in drug pricing chatter

Express Scripts Holding Co , the largest pharmacy benefit manager in the United States, said drug price inflation would likely be restrained going into 2017 and that scrutiny into pricing strategies was here to stay.

Short-seller Citron calls Express Scripts drug price culprit

Short seller Citron Research's Andrew Left has turned his sights on Express Scripts Holding Co, calling the pharmacy benefit manager (PBM) the "culprit behind pharmaceutical price gouging."

BRIEF-Express Scripts announces receipt of letter from internal revenue service

* Says on October 28, 2016, announced receipt of a letter from internal revenue service

Express Scripts gets subpoenas over drug company, pharmacy ties

Oct 25 Pharmacy benefit manager Express Scripts Holding Co has received subpoenas requesting information about its relationship with pharmaceutical companies, charitable foundations and specialty pharmacies, the company said in a regulatory filing on Tuesday.

BRIEF-Express Scripts Q3 earnings per share $1.15

* Narrowed its 2016 earnings per diluted share guidance from a range of $4.45 to $4.55 to a range of $4.47 to $4.53

Horizon Pharma to pay Express Scripts $65 million to settle rebate litigation

Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines.

Horizon Pharma to pay Express Scripts $65 mln to settle rebate litigation

Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines.

Horizon Pharma to pay Express Scripts $65 mln to settle rebate litigation

Sept 29 Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines.

BRIEF-Horizon Pharma says unit enters into settlement deal with Express Scripts - SEC filing

* On Sept 26, Horizon Pharma USA entered settlement agreement and mutual release with Express Scripts to settle litigation - SEC filing

Select another date: